Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Astellas Pharma Inc.

Market Cap 3,834B 23.93B 20.67B 19.05B 17.83B 33.41B 2,275B 33.93B 225B 87.69B 1,107B 89.82B 87.91B P/E Ratio 2026
15.5x
P/E Ratio 2027 * 11x
Enterprise Value 4,262B 26.61B 22.98B 21.18B 19.82B 37.15B 2,529B 37.72B 250B 97.49B 1,231B 99.86B 97.73B EV / Sales 2026
2.24x
EV / Sales 2027 * 1.66x
Free-Float
98.88%
Yield 2026
3.1%
Yield 2027 * 3.76%
1 day+1.57%
1 week-0.97%
Current month-6.26%
1 month-9.97%
3 months-9.38%
6 months+4.14%
Current year+2.25%
1 week 2,041
Extreme 2041
2,162.5
1 month 2,041
Extreme 2041
2,368
Current year 2,041
Extreme 2041
2,717
1 year 1,343.5
Extreme 1343.5
2,717
3 years 1,243.5
Extreme 1243.5
2,717
5 years 1,243.5
Extreme 1243.5
2,717
10 years 1,243.5
Extreme 1243.5
2,717
Manager TitleAgeSince
Chief Executive Officer 63 2023-02-09
Director of Finance/CFO 54 2023-10-31
Compliance Officer - 2025-03-31
Director TitleAgeSince
Chairman 66 2023-02-09
Director/Board Member 63 2019-05-31
Director/Board Member 69 2021-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.57%-0.97%+54.12%-6.57% 23.93B
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.07%+3.48%+53.32%+49.85% 580B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%0.00%+21.28%+16.70% 330B
-1.42%-1.44%+45.70%+8.24% 294B
-0.85%-2.86%+22.54%+14.67% 280B
+0.44%+3.48%+25.65%+35.66% 281B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+60.01% 192B
Average +0.25%+0.79%+25.60%+35.00% 359.1B
Weighted average by Cap. -0.32%+0.98%+30.00%+65.38%

Financials

2026 2027 *
Net sales 2,132B 13.31B 11.5B 10.59B 9.92B 18.58B 1,265B 18.87B 125B 48.77B 616B 49.95B 48.89B 2,244B 14.01B 12.1B 11.15B 10.44B 19.56B 1,332B 19.86B 132B 51.33B 648B 52.57B 51.46B
Net income 296B 1.85B 1.6B 1.47B 1.38B 2.58B 176B 2.62B 17.39B 6.78B 85.61B 6.95B 6.8B 350B 2.18B 1.89B 1.74B 1.63B 3.05B 208B 3.1B 20.53B 8B 101B 8.2B 8.02B
Net Debt 429B 2.68B 2.31B 2.13B 1.99B 3.74B 254B 3.79B 25.14B 9.8B 124B 10.04B 9.83B -103B -641M -554M -511M -478M -896M -60.97B -909M -6.03B -2.35B -29.68B -2.41B -2.36B
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
13,643
Date Price Change Volume
26-06-12 2,140.00 ¥ +1.57% 8,991,300
26-06-11 2,107.00 ¥ -1.57% 8,535,200
26-06-10 2,140.50 ¥ -0.19% 5,436,200
26-06-09 2,144.50 ¥ -0.21% 5,620,400
26-06-08 2,149.00 ¥ -0.56% 6,531,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,140.00JPY
Average target price
2,400.00JPY
Spread / Average Target
+12.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4503 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!